Maintenance therapies in bipolar disorders.

作者: Michael Gitlin , Mark A Frye

DOI: 10.1111/J.1399-5618.2012.00992.X

关键词:

摘要: Gitlin M, Frye MA. Maintenance therapies in bipolar disorders. Bipolar Disord 2012: 14 (Suppl. 2): 51–65. © 2012 The Authors. Journal compilation John Wiley & Sons A/S. Objective:  disorder is an inherently recurrent disorder, requiring maintenance preventive treatments the vast majority of patients. authors review data on highlighting controlled trial literature. Methods:  Literature using PubMed, Medline, and a hand search relevant literature. Results:  Over last decade, number effective for have been developed with evidence base second-generation antipsychotics some anticonvulsants. Increasing numbers patients, therefore, are appropriately treated multiple medications as regimen. For medications, treatment has demonstrated randomized trials both monotherapy combination other mood stabilizers. Lithium continues our oldest well-established somewhat better efficacy preventing mania than depression. Lamotrigine, olanzapine, quetiapine bimodal depression, although lamotrigine’s more robust depression olanzapine’s greater mania. Aripiprazole, ziprasidone, risperidone long-acting injection all prevent mania, but not Less investigations suggested stabilization carbamazepine, oxcarbazepine, adjunctive psychotherapy. Conclusions:  Despite agents optimal regimens still evidence-based therapy individualized creative algorithms.

参考文章(93)
Cochran Sd, Gitlin Mj, Jamison Kr, Maintenance lithium treatment: side effects and compliance. The Journal of Clinical Psychiatry. ,vol. 50, pp. 127- 131 ,(1989)
Ross J Baldessarini, Paola Salvatore, Hari-Mandir Kaur Khalsa, Priscilla Gebre-Medhin, Harkaitz Imaz, Ana González-Pinto, Jesus Perez, Núria Cruz, Carlo Maggini, Mauricio Tohen, Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disorders. ,vol. 12, pp. 264- 270 ,(2010) , 10.1111/J.1399-5618.2010.00812.X
Veronica Pitt, Dianne Lowe, Sophie Hill, Megan Prictor, Sarah E Hetrick, Rebecca Ryan, Lynda Berends, Consumer‐providers of care for adult clients of statutory mental health services Cochrane Database of Systematic Reviews. ,vol. 3, pp. 1- 105 ,(2013) , 10.1002/14651858.CD004807.PUB2
Earlian E. Smith-Jackson, David Luckenbaugh, Mark A. Frye, Gabriele S. Leverich, Robert M. Post, S. Omar Ali, Ann L. Bryan, Kirk D. Denicoff, Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. American Journal of Psychiatry. ,vol. 156, pp. 1909- 1914 ,(1999) , 10.1176/AJP.156.12.1909
Relapse and impairment in bipolar disorder. American Journal of Psychiatry. ,vol. 152, pp. 1635- 1640 ,(1995) , 10.1176/AJP.152.11.1635
Marianna Mazza, Marco Di Nicola, Giovanni Martinotti, Colombo Taranto, Gino Pozzi, Gianluigi Conte, Luigi Janiri, Pietro Bria, Salvatore Mazza, Oxcarbazepine in bipolar disorder: a critical review of the literature. Expert Opinion on Pharmacotherapy. ,vol. 8, pp. 649- 656 ,(2007) , 10.1517/14656566.8.5.649
Ross J. Baldessarini, Leonardo Tondo, Gianni L. Faedda, Trisha R. Suppes, Gianfranco Floris, Nereide Rudas, Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. The Journal of Clinical Psychiatry. ,vol. 57, pp. 441- 448 ,(1996) , 10.4088/JCP.V57N1001
Elizabeth A. Koller, Jena Weber, P. Murali Doraiswamy, Bruce S. Schneider, A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. The Journal of Clinical Psychiatry. ,vol. 65, pp. 857- 863 ,(2004) , 10.4088/JCP.V65N0619
Michael Gitlin, Lithium and the kidney: an updated review. Drug Safety. ,vol. 20, pp. 231- 243 ,(1999) , 10.2165/00002018-199920030-00004